We should further elucidate the mechanism by which orientin suppresses Dex-activated PPARγ expression and conduct an in vivo study to evaluate the anti-obesity properties of orientin. The gene discussed is PPARG; the disease is obesity due to melanocortin 4 receptor deficiency.